Prepared by Dr. David Miller, CFA, Senior Equity Strategist | Reviewed by Anna Kowalski, Lead Editor | Report ID: IGEMINI-387BE546-20260531 | Data as of 2026-05-31
Executive Summary: Analysis of cash flow vs profit reveals a Cautiously Constructive configuration: technical patterns show a Bull Flag formation, while fundamentals are supported by 98.91 EPS and a 4.57% yield. Institutional flows indicate 72% ownership with beta of 1.85.
Rating: Accumulate | Target Price: $7774.8 | Next Earnings: Jun 28
Download Full PDF Report
Price action carved a Double Bottom, confirmed by a 1.5x volume spike on May 17, 2026. The resistance at $5301 was tested.
On-chain money flow shows 33%% increase in smart money index, reinforcing the technical setup.
Bollinger Bands contracted to the 15th percentile, signaling a breakout. A close above $6773.5 would be bullish.
With a market cap of $0.24B, cash flow vs profit operates in Healthcare. P/E of 59.55x is backed by 40.9% growth.
EPS of $98.91 reveals high earnings quality. DuPont analysis highlights asset turnover as the key ROE driver.
Options skew is toward put at the 5772.2 strike, positioning for a directional move.
Beta of 1.85 suggests cash flow vs profit is {beta_desc} volatile than the market, influencing hedging strategies.
| Metric | Value | Sector Avg |
|---|---|---|
| Last Price | $5890 | $5595.5 |
| Market Cap | $0.24B | $0.24B |
| P/E Ratio | 59.55x | 50.6x |
| EPS (TTM) | $98.91 | $89.02 |
| Dividend Yield | 4.57% | 3.2% |
| Revenue Growth | 40.9% | 24.5% |
| Target Price | $7774.8 | - |
| Beta | 1.85 | 1.00 |